Ra Medical Systems, Inc. (RMED) financial statements (2021 and earlier)

Company profile

Business Address 2070 LAS PALMAS DRIVE
CARLSBAD, CA 92011
State of Incorp.
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:3164
Cash and cash equivalents1564
Other undisclosed cash, cash equivalents, and short-term investments16 
Receivables11
Inventory, net of allowances, customer advances and progress billings32
Inventory32
Other undisclosed current assets22
Total current assets:3669
Noncurrent Assets
Operating lease, right-of-use asset3
Property, plant and equipment55
Other noncurrent assets00
Total noncurrent assets:85
TOTAL ASSETS:4474
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities44
Accounts payable21
Accrued liabilities33
Deferred revenue2
Debt0 
Contract with customer, liability2
Other undisclosed current liabilities00
Total current liabilities:76
Noncurrent Liabilities
Long-term debt and lease obligation3 
Operating lease, liability3
Liabilities, other than long-term debt11
Deferred revenue1
Contract with customer, liability1
Other liabilities 0
Other undisclosed noncurrent liabilities01
Total noncurrent liabilities:41
Total liabilities:117
Stockholders' equity
Stockholders' equity attributable to parent3367
Common stock00
Additional paid in capital150127
Accumulated other comprehensive income0 
Accumulated deficit(117)(60)
Total stockholders' equity:3367
TOTAL LIABILITIES AND EQUITY:4474

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
Revenues76
Cost of revenue
(Cost of Goods and Services Sold)
(9)(4)
Gross profit:(2)2
Operating expenses(56)(33)
Operating loss:(58)(31)
Nonoperating income10
Investment income, nonoperating10
Interest and debt expense(0)(0)
Loss from continuing operations before equity method investments, income taxes:(57)(31)
Other undisclosed income from continuing operations before income taxes00
Loss from continuing operations before income taxes:(57)(31)
Income tax expense(0)(0)
Net loss available to common stockholders, diluted:(57)(31)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
Net loss:(57)(31)
Other comprehensive income0 
Comprehensive loss, net of tax, attributable to parent:(57)(31)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: